Literature DB >> 3957435

Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.

R Haag.   

Abstract

Two strains each of sensitive, penicillinase-producing, methicillin-resistant and "tolerant" Staphylococcus aureus were used to infect mice intramuscularly. The mice were then treated with three doses each of fosfomycin, vancomycin, rifampicin, fusidic acid, penicillin G, flucloxacillin or cefazolin intravenously. Infections due to sensitive strains were effectively treated with all antibiotics investigated except fusidic acid. Fosfomycin, vancomycin, rifampicin and flucloxacillin showed the best activity against penicillinase-producing strains. Fosfomycin and vancomycin were equally effective against infections due to methicillin-resistant S. aureus. Infections caused by "tolerant" strains again responded best to fosfomycin, vancomycin and rifampicin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957435     DOI: 10.1007/bf01644810

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  44 in total

1.  [Staphylococcus strains naturally resistant to methicillin and 5-methyl-3-phenyl-4-iso-oxazolyl-penicillin].

Authors:  Y A CHABBERT; J G BAUDENS
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-08

2.  The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Ann Intern Med       Date:  1950-09       Impact factor: 25.391

3.  Fucidin-resistant staphylococci in current hospital practice.

Authors:  J R Pattison; P E Mansell
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

4.  The incidence and development of resistance in Staphylococcus aureus from three European countries.

Authors:  B Wiedemann; M Kresken
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

5.  Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.

Authors:  K Ishida; P A Guze; G M Kalmanson; K Albrandt; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

6.  [Sensitivity of bacteria to chemotherapeutic agents (Zurich 1980). Part I. Bacteria isolated from hospital patients].

Authors:  F H Kayser; J Wüst; J Munzinger
Journal:  Schweiz Med Wochenschr       Date:  1982-03-20

7.  Treatment of mice infected with methicillin-resistant Staphylococcus aureus.

Authors:  D R Moorman; J E Peacock; G L Mandell
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

8.  The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats.

Authors:  P A Guze; G M Kalmanson; L B Guze
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

9.  In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  W Graninger; T Leitha; M Havel; A Georgopoulos
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

10.  Serious staphylococcal infections with strains tolerant to bactericidal antibiotics.

Authors:  A E Denny; L R Peterson; D N Gerding; W H Hall
Journal:  Arch Intern Med       Date:  1979-09
View more
  2 in total

1.  Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.

Authors:  J D Knudsen; K Fuursted; S Raber; F Espersen; N Frimodt-Moller
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.

Authors:  S Gatermann; E Schulz; R Marre
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.